Greenland Mines Ltd
GRML · XNASCIK 1907223fmd_12K4EFJ9FJYMVXJZ6SKWHKRJ4SManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Mar 16, 2021 to Jun 30, 2026, 20 periods
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Research and development | – | 0 | 0 | 1 |
| Total operating expenses | – | 1 | 6 | 7 |
| Operating income | (1) | (1) | (6) | (7) |
| Interest expense | – | 0 | 0 | 2 |
| Interest and investment income | 2 | 3 | – | – |
| Other non-operating income (expense) | – | (0) | (1) | (3) |
| Income before taxes | 2 | (1) | (6) | (11) |
| Income tax expense | 0 | 1 | – | – |
| Net income from continuing operations | 1 | (1) | – | – |
| Net income | 1 | (1) | (6) | (11) |
| Net income to common shareholders | 1 | 1 | – | – |